These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22785557)

  • 1. Serum blood urea nitrogen and plasma brain natriuretic Peptide and low diastolic blood pressure predict cardiovascular morbidity and mortality following discharge in acute decompensated heart failure patients.
    Chen CY; Yoshida A; Asakura M; Hasegawa T; Takahama H; Amaki M; Funada A; Asanuma H; Yokoyama H; Kim J; Kanzaki H; Kitakaze M
    Circ J; 2012; 76(10):2372-9. PubMed ID: 22785557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic combined role of B-type natriuretic peptide, blood urea nitrogen and congestion signs persistence in patients with acute heart failure.
    Ruocco G; Pellegrini M; De Gori C; Franci B; Nuti R; Palazzuoli A
    J Cardiovasc Med (Hagerstown); 2016 Nov; 17(11):818-27. PubMed ID: 26702597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sodium concentration, blood urea nitrogen, and outcomes in patients hospitalized for acute decompensated heart failure.
    Kajimoto K; Minami Y; Sato N; Takano T;
    Int J Cardiol; 2016 Nov; 222():195-201. PubMed ID: 27497094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utilization and prognostic impact of B-type Natriuretic Peptide in hospitalized acute decompensated heart failure in an Asian population.
    Chen LJ; Hung CL; Yeh HI; Jeng MJ; Su CH; Wu TY; Shih SC; Tsai CH
    BMC Cardiovasc Disord; 2016 Sep; 16(1):178. PubMed ID: 27613439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.
    Casado J; Sánchez M; Garcés V; Manzano L; Cerqueiro JM; Epelde F; García-Escrivá D; Pérez-Silvestre J; Morales JL; Montero-Pérez-Barquero M;
    Int J Cardiol; 2017 Sep; 243():332-339. PubMed ID: 28528982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nesiritide, renal function, and associated outcomes during hospitalization for acute decompensated heart failure: results from the Acute Study of Clinical Effectiveness of Nesiritide and Decompensated Heart Failure (ASCEND-HF).
    van Deursen VM; Hernandez AF; Stebbins A; Hasselblad V; Ezekowitz JA; Califf RM; Gottlieb SS; O'Connor CM; Starling RC; Tang WH; McMurray JJ; Dickstein K; Voors AA
    Circulation; 2014 Sep; 130(12):958-65. PubMed ID: 25074507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of blood urea nitrogen in predicting the post-discharge prognosis in elderly patients with acute decompensated heart failure.
    Ren X; Qu W; Zhang L; Liu M; Gao X; Gao Y; Cheng X; Xu W; Liu Y
    Sci Rep; 2018 Sep; 8(1):13507. PubMed ID: 30202087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
    Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictability of renin-angiotensin-aldosterone system factors for clinical outcome in patients with acute decompensated heart failure.
    Nakada Y; Takahama H; Kanzaki H; Sugano Y; Hasegawa T; Ohara T; Amaki M; Funada A; Yoshida A; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 Jun; 31(6):925-31. PubMed ID: 25964073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
    Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
    Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Salah K; Pinto YM; Eurlings LW; Metra M; Stienen S; Lombardi C; Tijssen JG; Kok WE
    Am Heart J; 2015 Sep; 170(3):531-42.e1. PubMed ID: 26385037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood urea nitrogen variation upon admission and at discharge in patients with heart failure.
    Khoury J; Bahouth F; Stabholz Y; Elias A; Mashiach T; Aronson D; Azzam ZS
    ESC Heart Fail; 2019 Aug; 6(4):809-816. PubMed ID: 31199082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients.
    Oh J; Kang SM; Won H; Hong N; Kim SY; Park S; Lee SH; Jang Y; Chung N
    Circ J; 2012; 76(1):109-16. PubMed ID: 22033347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain natriuretic peptide at discharge as a predictor of 6-month mortality in acute decompensated heart failure.
    Naffaa M; Makhoul BF; Tobia A; Jarous M; Kaplan M; Aronson D; Saliba W; Azzam ZS
    Am J Emerg Med; 2014 Jan; 32(1):44-9. PubMed ID: 24210886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responder to BNP-guided treatment in heart failure. The process of defining a responder.
    Karlström P; Dahlström U; Boman K; Alehagen U
    Scand Cardiovasc J; 2015; 49(6):316-24. PubMed ID: 26153427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Stratification of Acute Kidney Injury Using the Blood Urea Nitrogen/Creatinine Ratio in Patients With Acute Decompensated Heart Failure.
    Takaya Y; Yoshihara F; Yokoyama H; Kanzaki H; Kitakaze M; Goto Y; Anzai T; Yasuda S; Ogawa H; Kawano Y
    Circ J; 2015; 79(7):1520-5. PubMed ID: 25854814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ADHF/NT-proBNP risk score to predict 1-year mortality in hospitalized patients with advanced decompensated heart failure.
    Scrutinio D; Ammirati E; Guida P; Passantino A; Raimondo R; Guida V; Sarzi Braga S; Canova P; Mastropasqua F; Frigerio M; Lagioia R; Oliva F
    J Heart Lung Transplant; 2014 Apr; 33(4):404-11. PubMed ID: 24485712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
    Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF
    J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.